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Items for this week’s Epi Update include: 
 Use of antivirals for influenza 
 Interim estimates of 2018-19 seasonal influenza vaccine effectiveness 
 In the news: Can exercise prevent depression? Here’s what the science says  
 In the news: Why are Americans in so much pain? 
 In the news: What’s healthy at the grocery store? Shoppers are often confused, 
survey finds 
 Infographic: Protect babies from whooping cough 
 Meeting announcements and training opportunities 
 
Use of antivirals for influenza 
There are several antiviral treatment and prophylaxis options available to help manage 
influenza. These treatments are most effective in healthy people when given within 48 hours of 
symptom onset, and can reduce uncomplicated illness by up to one day. In young children, 
they may reduce illness by 3 ½ half days if given within 24 hours of symptom onset. In 
pregnant women, they have been shown to reduce respiratory failure and death when started 
within three days. Treatment with antivirals can also reduce secondary pneumonia in adults by 
50 percent, and also reduce the risk of death. 
 
Groups at higher risk of complications include: hospitalized patients with confirmed or suspect 
influenza, patients with severe illness, those under 2 or over 65 years, those with chronic 
diseases, pregnant women, children on aspirin, morbidly obese, long term care residents and 
American Indian/Alaskan Native populations. 
 
Antivirals can also be used for post-exposure prophylaxis and should be given within 48 hours 
of the last exposure and for 7 days following the last known exposure. Antivirals can be 
considered for preventing flu in persons who are at high risk of complications who cannot 
receive the flu vaccine or in the first two weeks after receiving the vaccine or as prevention for 
persons with severe immune deficiencies who might not respond to flu vaccination. Antivirals 
can also be used to help control outbreaks among high risk persons in an institutional setting. 
Based on guidance from the CDC and ISDA, the target population for antiviral prophylaxis 
might vary according to the layout of an institution and the potential for exposures among the 
institutionalized population. 
 
Neuraminidase inhibitors that can be used for treatment or prophylaxis include Zanamivir and 
Oseltamivir. Peramivir is an additional treatment option. And this year there is a new 
medication, Baloxavir, available as a treatment option. See the link below for dosing 
information. 
 
For more information visit: www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm. 
 
Interim estimates of 2018-19 seasonal influenza vaccine effectiveness 
The interim vaccine effectiveness (VE) estimates for the 2018-19 season influenza vaccine 
were released in the February 15 edition of the Morbidity and Mortality Weekly Report. These 
estimates indicate the adjusted overall VE against influenza-associated medically attended 
acute respiratory illness was 47 percent (95% confidence interval of 34-57%). This estimate is 
within the range of recent seasons (40% to 60%) when the recommended vaccine viruses 
have been well-matched to most circulating viruses. 
  
The VE estimates were similar for H1N1 at 46% (95% CI = 30-58%) and H3N2 at 44% (13-
64%), but varied widely by age. The highest overall effectiveness was 61 percent among 
children aged 6 months to 17 years and the lowest effectiveness was 24 percent (-15 to 51%) 
for those 50 years and over. The VE against H3N2 was higher than in 2017-18, but similar to 
previous well-matched H3N2 seasons. 
  
The interim U.S. VE estimate of 44 percent against H1N1 is lower than the recently reported 
interim estimates of 72% effectiveness against H1N1 in Canada during the 2018–2019 season 
and 78% against H1N1 in Australia during the 2018 Southern Hemisphere influenza season. It 
is not currently known if this difference is due to variation in the circulating viruses or due to 
differences in the populations studied. 
  
Estimates for flu-related hospitalizations and deaths prevented by the 2018-19 influenza 
vaccine will not be available until the season is over, but estimates from other similar seasons 
indicate millions of flu illnesses and thousands of hospitalizations and deaths will be prevented 
through vaccination this season. 
 
For more information, visit www.cdc.gov/mmwr/volumes/68/wr/mm6806a2.htm.  
 
In the news: Can exercise prevent depression? Here’s what the science says 
time.com/5511322/exercise-depression-mental-health/  
 
In the news: Why are Americans in so much pain? 
news.yahoo.com/americans-much-pain-141918964.html  
 
In the news: What’s healthy at the grocery store? Shoppers are often confused, survey 
finds 
www.npr.org/sections/thesalt/2019/01/24/688042266/grocery-shoppers-dont-always-know-
what-s-best-for-them-can-better-food-labeling  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Infographic: Protect babies from whooping cough 
 
 
 
To view in full size, visit www.cdc.gov/vaccines/parents/infographics/protect-babies-from-
whooping-cough.pdf.    
 
Meeting announcements and training opportunities 
None 
 
Have a healthy and happy week! 
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